US HB877 | 2009-2010 | 111th Congress
Status
Spectrum: Partisan Bill (Republican 47-2)
Status: Introduced on February 4 2009 - 25% progression, died in committee
Action: 2009-02-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 4 2009 - 25% progression, died in committee
Action: 2009-02-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Patients First Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not such pluripotent stem cells have an embryonic source), provided that such techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this Act. Requires the Secretary to issue guidelines implementing this Act to ensure that any research (including any clinical trial) supported under this Act: (1) is clearly consistent with the standards established in this Act, if conducted using human cells; (2) is prioritized in terms of potential for near-term clinical benefit in human patients; and (3) may take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.Requires the Secretary to: (1) report on peer reviewed stem cell research proposals that were not funded; and (2) study and submit recommendations to Congress on any structural changes to the C.W. Bill Young Cell Transplantation Program that would help to expand access to new and future stem cell therapeutic products.
Title
Patients First Act of 2009
Sponsors
History
Date | Chamber | Action |
---|---|---|
2009-02-09 | Referred to the Subcommittee on Health. | |
2009-02-04 | Referred to the House Committee on Energy and Commerce. |
Subjects
Administrative law and regulatory procedures
Cell biology and embryology
Department of Health and Human Services
Government investigations
Health
Medical ethics
Medical research
Research administration and funding
Cell biology and embryology
Department of Health and Human Services
Government investigations
Health
Medical ethics
Medical research
Research administration and funding
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/111th-congress/house-bill/877/all-info |
Text | https://www.congress.gov/111/bills/hr877/BILLS-111hr877ih.pdf |